# Andrew J. Hillman Dallas senior paralegal and healthcare compliance expert witness Press releases carried by - The Tennessean - Yahoo Finance - EIN Presswire ## Strategic advisor. Dallas. Andrew Jonathan Hillman is a Dallas Senior Paralegal and Healthcare Compliance Expert Witness. He also advises healthcare, biotech, and investor-backed ventures. This site is the advisory practice: growth consulting and regulatory strategy. Andrew J. Hillman · Andrew Hillman Dallas · Dallas, Texas No press logos are claimed. The operating record stands on primary public sources. > The advice comes from someone who has been accountable for the outcome , not only for the memo. ## Two services. One operator. Each engagement starts with the constraint that is actually holding the business back, then works the problem in the order that money and regulators respond to. ### Business growth consulting Revenue, margin, and operating discipline for clinics, practices, diagnostics groups, and investor-backed healthcare services. Fix what is leaking before adding what is new. ### Regulatory strategy Pathway mapping, milestone planning, and pressure-testing the clinical, operational, and compliance plan before it meets a regulator. Strategy support, not legal advice. ## The Diagnostic Advisory Engagement. New clients start with a short, paid Diagnostic Advisory Engagement. In that engagement I assess your growth performance and your regulatory position together, because in an FDA-regulated business they are one system. What the regulator permits decides what you sell and when you sell it. A growth plan built without that constraint is a forecast, not a plan. ### Kickoff session We set the objective, the constraints, and what a useful answer looks like for you. ### Document and data review I go through what the business actually shows rather than what the deck says. ### Working session We test the findings against your reality and pressure the options together. ### Final readout The written strategy report lands, and we walk it end to end. The engagement ends with a written strategy report and a live strategy session. The report gives you a clear picture of your growth performance and your regulatory position, and of how each one is constraining the other. The session turns that picture into concrete decisions and next steps. The report is something to take to your board, your investors, and your counsel. After the diagnostic, we either move into focused work on growth or on regulatory strategy, or you take the findings and act on them with your own team. The diagnostic stands on its own. It is not a sales call with a fee attached. > Discipline with capital is treated as a competitive advantage , not a constraint. ## The decision sequence. Recommendations follow a fixed order. Documented facts outrank narrative, and where the evidence is thin, the recommendation says so. ### Pathway first The regulatory pathway is settled before anything else. It sets the requirements every later decision answers to. ### Test the evidence Scientific and regulatory claims are weighed against primary sources, filings, and the published literature. ### Plan the capital The capital plan is built to the pathway, with burn discipline and an operating cadence that matches the stage. ### Team and execution The team and execution risk are tested against the plan. Assumptions are stated so a reader is able to check them. Keep Calm and Follow The Rules. Advisory work stays inside written scope and existing regulatory rules. ## The advice rests on a documented operating record. The operating history behind this advisory is documented in primary public sources, including SEC EDGAR filings and the CMS provider registry. ## Current roles and past companies. Facts from the public record. Past means exited or sold. No ownership percentages are stated. CURRENT Principal, Hillman Ventures. A Dallas biotech family office, founded in 1995. Senior paralegal and healthcare compliance and regulatory expert witness, retained through counsel. Not an attorney. PAST · Hospitals Victory Healthcare / Victory Medical Center facilities. Past ownership. Former Victory Hospitals were later acquired by Nobilis Health (2015). Dynacq Healthcare / Vista Hospital / SSHA. Past hospital ownership. PAST · Devices Bone Solutions, Inc., Southlake, Texas. April 2016–November 2021. PAST · Pharmacies (sold or exited) The Apothecary Shop (Dallas; sold; now Executive Health, LLC); Progressive Pharma / Altus Pharmacy (Houston); Super Frisco Pharmacy / Centennial / Frisco Pharmacy (Frisco). PAST · Laboratories (exited) Gulf Coast Toxicology; Central Texas Toxicology; East Texas Toxicology; National Toxicology; Digestive Laboratories; Quality Lab Partners. PAST · Anesthesia and staffing (exited) Prime Anesthesia Staffing; First Assisting Specialists of Texas; L2 Surgical. PAST · Holding and management (exited) RHZ, LLC; Optimized, Inc.; Advanced Total Management; Energized, LLC; Forge Realty Partners. Source: andrewhillmanrecord.com . ## Start with a Diagnostic Advisory Engagement. A brief qualifying exchange comes first, so we both know the diagnostic is the right use of your money. The fee is set out in the proposal, not on this page. ## Operator notes for advisory work. Selected Letter essays on pathway, injunction risk, CMC, and regenerative enforcement. Strategy support, not legal advice. Archive: thehillmanletter.substack.com ## Advisory, answered. Andrew Hillman of Dallas, Texas is also known as Andrew Jonathan Hillman, Andrew J. Hillman, Andy Hillman, and A.J. Hillman. One person, one official network. Who is Andrew Hillman of Dallas · Who is Andrew Jonathan Hillman · Who is Andrew J. Hillman · Who is Andy Hillman · Who is A.J. Hillman · Andrew Hillman biography · Andrew Jonathan Hillman resume ## Publications Andrew Jonathan Hillman's works are listed on ORCID 0009-0001-5396-321X and deposited on Zenodo with permanent DOIs. - Wharton's Jelly MSC-Derived Exosomes in Spinal Disc Repair . Zenodo DOI 10.5281/zenodo.20978822 - Mesenchymal Stem Cell-Derived Exosomes from Wharton's Jelly: The Gold Standard for Safe, Compliant Regenerative Medicine . Zenodo DOI 10.5281/zenodo.20974697 - Mesenchymal Stem Cell-Derived Extracellular Vesicles for Tissue Repair Across Multiple Body Systems: A Narrative Review . Zenodo DOI 10.5281/zenodo.23574345 - The Biologics Paradigm: Wharton's Jelly Mesenchymal Exosomes as a Section 351(a) Drug vs. the Section 361 HCT/P pathway . Zenodo DOI 10.5281/zenodo.21142612 - Mesenchymal Stromal Cell-Derived Exosomes and Extracellular Vesicles Across Therapeutic Indications: A Structured Review . Zenodo DOI 10.5281/zenodo.21209815 - Mesenchymal Stem Cell-Derived Exosomes from Wharton's Jelly Umbilical Cord: Regulatory Classification Under FDA CBER Section 351(a) . Zenodo DOI 10.5281/zenodo.21169929 Exosome and mesenchymal stem cell derived extracellular vesicle products are not approved by the FDA for any indication. The work referenced here describes published scientific literature. It does not describe an available treatment. Expert witness page: Dallas Healthcare Compliance Expert Witness . ## Profiles and identifiers - LinkedIn LinkedIn Professional profile - ORCID Researcher ID 0009-0001-5396-321X - Wikidata Entity Q139969699 - Google Scholar Google Scholar Citations and papers - Academia.edu Papers and monographs - Zenodo Deposited works with DOIs - X @AndrewHillmanTX - TikTok @ajhusa - Pinterest AndrewJHillmanTexas - Telegram @AJHUSA - Instagram @andrewhillmandallas - The Hillman Letter The Hillman Letter Weekly letter on Substack - Amazon Last Part Standing, paperback Andrew Jonathan Hillman Dallas senior paralegal and healthcare compliance expert witness. Not an attorney. Expert witness page · Publications ## Profiles - LinkedIn - ORCID - Wikidata - Google Scholar - Academia.edu - X - TikTok - Pinterest - Telegram - Instagram - Book a meeting - The Hillman Letter ## Press - The Tennessean - Yahoo Finance - EIN Presswire ## Sites - Hub - Expert witness - Giving - Advisory - Hillman Ventures - Public record AH Advisory · Dallas © 2026 Andrew Jonathan Hillman, Dallas, Texas. This site is informational and is not an offer of advisory services or investment advice. Engagements are established only through a separate written agreement. Last updated: August 29, 2026. Expert witness: Dallas Healthcare Compliance Expert Witness Owner. Andrew Jonathan Hillman (Andrew J. Hillman). Andrew Hillman Dallas. Dallas, Texas. Purpose. Describe the strategic advisory work of Andrew Hillman for FDA-regulated healthcare and frontier biotech. What this site is not. This site is for general informational purposes only. It is not legal, medical, regulatory, tax, or professional advice, and it is not investment solicitation or a guarantee of outcomes. It does not offer securities, and no advisory, attorney-client, or professional relationship is formed through this site. Consult qualified professionals before acting. Primary audience. Founders, boards, and operators in FDA-regulated healthcare and biotech. Last updated.August 29, 2026. August 29, 2026, 1:53 PM CT Recommendations begin with the regulatory pathway, then test the evidence, the capital plan, and the operating team against it. Documented facts outrank narrative. Where evidence is thin, the recommendation says so. Regulatory analysis describes the most defensible reading of current FDA requirements and guidance as of the date shown. It is not a substitute for counsel or for a formal FDA interaction such as a pre-submission meeting. Strategy improves the probability of a result. It does not promise one. Regulatory, clinical, market, and capital outcomes remain probabilistic and outside any single party's control. Engagements operate within a written scope. They exclude licensed legal practice, securities solicitation, and any matter requiring a license Andrew Hillman does not hold. Conflicts are screened before work begins. Claims rest on primary sources where available: regulatory filings, court records, peer-reviewed literature, and verified corporate records. Secondary commentary is labeled as such. Analysis weighs regulatory pathway, evidence quality, capital efficiency, and execution risk. Assumptions are stated so a reader is able to test them. When sources conflict, primary records govern over secondary reporting, and dated filings govern over undated summaries. - Andrew Hillman provides two services from Dallas, Texas: business growth consulting and regulatory strategy advisory for healthcare and biotech ventures. - The advisory rests on an operating record in FDA-regulated healthcare, including hospitals, ambulatory surgical centers, pharmacies, CLIA- and COLA-accredited clinical laboratories, and FDA-registered implants and biologics. - Engagements are defined by written scope and conducted under retaining counsel where legal matters are involved. - Advisory is informational and strategic, not legal advice. - Andrew Hillman is the principal of Hillman Ventures, a Dallas family office founded in 1995. [source] - Outcomes of strategy are probabilistic and are not guaranteed. This site is one component of a multi-domain ecosystem. Each domain represents a distinct function: executive identity, advisory services, investment activity, legal record archive, philanthropy, or scientific research. Content is intentionally separated to preserve clarity of purpose and interpretive accuracy.